Tag: cse:lxx

August 27, 2019

Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce...
August 21, 2019

Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil

Lexaria Bioscience Corp. (OTC:LXRP, CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce...
August 15, 2019

Lexaria Bioscience Announces it has Received Four New Patents

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce...
August 14, 2019

Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce...
August 13, 2019

Lexaria Bioscience Receives Cannabis R&D License from Health Canada

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce...
August 8, 2019

Lexaria Bioscience Completes Initial Project with Canada’s National Research Council

Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP), (the “Company” or “Lexaria”) an innovator in drug delivery platforms, announces the successful completion of...
August 5, 2019

Cannabis Investment: Canadian Cannabis Stocks

Are you interested in cannabis investment? Here's a list of Canadian marijuana stocks for investors to reference.